Concepedia

Publication | Closed Access

Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation

51

Citations

25

References

2011

Year

References

YearCitations

Page 1